Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD34 antibody (FITC)

This Mouse Monoclonal antibody specifically detects CD34 in FACS. It exhibits reactivity toward Human, Non-Human Primate and has been mentioned in 9+ publications.
Catalog No. ABIN1027678

Quick Overview for CD34 antibody (FITC) (ABIN1027678)

Target

See all CD34 Antibodies
CD34

Reactivity

  • 310
  • 110
  • 109
  • 33
  • 20
  • 19
  • 19
  • 19
  • 18
  • 17
  • 9
  • 8
  • 5
  • 1
  • 1
Human, Non-Human Primate

Host

  • 170
  • 159
  • 16
  • 4
  • 1
  • 1
Mouse

Clonality

  • 220
  • 128
  • 2
Monoclonal

Conjugate

  • 147
  • 29
  • 28
  • 20
  • 12
  • 7
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD34 antibody is conjugated to FITC

Application

  • 232
  • 211
  • 88
  • 84
  • 60
  • 52
  • 46
  • 39
  • 37
  • 34
  • 28
  • 26
  • 13
  • 7
  • 5
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
Flow Cytometry (FACS)

Clone

581
  • Purpose

    Anti-Hu CD34 FITC

    Specificity

    The mouse monoclonal antibody 581 reacts with an extracellular epitope of CD34, a 110-115 kDa monomeric transmembrane phosphoglycoprotein expressed on hematopoietic progenitors cells and on the most pluripotential stem cells, it is gradually lost on progenitor cells. The antibody recognizes the class III CD34 epitope resistant to neuraminidase, chymopapain and glycoprotease.

    No Cross-Reactivity

    Sheep

    Cross-Reactivity (Details)

    Human, Non-Human Primates

    Purification

    Purified antibody is conjugated with fluorescein isothiocyanate (FITC) under optimum conditions and unconjugated antibody and free fluorochrome are removed by size-exclusion chromatography.

    Isotype

    IgG1 kappa
  • Application Notes

    Flow cytometry: The reagent is designed for analysis of human blood cells using 4 μL reagent / 100 μL of whole blood or 106 cells in a suspension. The content of a vial (0.4 ml) is sufficient for 100 tests.

    Restrictions

    For Research Use only
  • Reconstitution

    No reconstitution is necessary.

    Buffer

    Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Do not freeze.
    Avoid prolonged exposure to light.

    Storage

    4 °C

    Storage Comment

    Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
  • Sanz, Muñoz-A, Monserrat, Van-Den-Rym, Escoll, Ranz, Alvarez-Mon, de-la-Hera: "Ordering human CD34+CD10-CD19+ pre/pro-B-cell and CD19- common lymphoid progenitor stages in two pro-B-cell development pathways." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Issue 13, pp. 5925-30, (2010) (PubMed).

    Goardon, Nikolousis, Sternberg, Chu, Craddock, Richardson, Benson, Drayson, Standen, Vyas, Freeman: "Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes." in: Haematologica, Vol. 94, Issue 8, pp. 1160-3, (2009) (PubMed).

    Ninos, Jefferies, Cogle, Kerr: "The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells." in: Journal of translational medicine, Vol. 4, pp. 9, (2006) (PubMed).

    Ono, Sharma, Smith, Burnett, Aurelian: "CD34+ cells in the peripheral blood transport herpes simplex virus DNA fragments to the skin of patients with erythema multiforme (HAEM)." in: The Journal of investigative dermatology, Vol. 124, Issue 6, pp. 1215-24, (2005) (PubMed).

    Kato, Ando, Nakamura, Muguruma, Sato, Yabe, Yabe, Hattori, Yasuda, Hotta: "Absence of a CD34- hematopoietic precursor population in recipients of CD34+ stem cell transplantation." in: Bone marrow transplantation, Vol. 28, Issue 6, pp. 587-95, (2001) (PubMed).

    Felschow, McVeigh, Hoehn, Civin, Fackler: "The adapter protein CrkL associates with CD34." in: Blood, Vol. 97, Issue 12, pp. 3768-75, (2001) (PubMed).

    Ando, Nakamura, Chargui, Matsuzawa, Tsuji, Kato, Hotta: "Extensive generation of human cord blood CD34(+) stem cells from Lin(-)CD34(-) cells in a long-term in vitro system." in: Experimental hematology, Vol. 28, Issue 6, pp. 690-9, (2000) (PubMed).

    Fluckiger, Sanz, Garcia-Lloret, Su, Hao, Kato, Quan, de la Hera, Crooks, Witte, Rawlings: "In vitro reconstitution of human B-cell ontogeny: from CD34(+) multipotent progenitors to Ig-secreting cells." in: Blood, Vol. 92, Issue 12, pp. 4509-20, (1999) (PubMed).

    Janowska-Wieczorek, Marquez, Nabholtz, Cabuhat, Montaño, Chang, Rozmus, Russell, Edwards, Turner: "Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane." in: Blood, Vol. 93, Issue 10, pp. 3379-90, (1999) (PubMed).

  • Target

    CD34

    Alternative Name

    CD34

    Background

    CD34 Molecule,CD34 is a highly glycosylated monomeric 111-115 kDa surface protein, which is present on many stem cell populations. It is a well established stem cell marker, though its expression on human hematopoietic stem cells is reversible. CD34 probably serves as a surface receptor that undergoes receptor-mediated endocytosis and regulates adhesion, differentiation and proliferation of hematopoietic stem cells and other progenitors. CD34 expression is likely to represent a specific state of hematopoietic development that may have altered adhering properties with expanding and differentiating capabilities in both in vitro and in vivo conditions.

    Gene ID

    947

    UniProt

    P28906
You are here:
Chat with us!